Company Profile
Bicycle Therapeutics, Inc.
Company Overview
Bicycle Therapeutics is developing a new class of medicines to treat oncology and other important diseases based on its proprietary bicyclic peptides (Bicycles®) product platform. Bicycle Therapeutics is rapidly advancing towards the clinic with its lead programs using Bicycle Drug Conjugates® (BDCs. Bicycle Therapeutics is collaborating in oncology and other areas to realize the full potential of the technology). Bicycle Therapeutics is headquartered in Cambridge, U.K., with U.S. operations in Cambridge, Massachusetts. For more information, visit: www.bicycletherapeutics.com.